Noninvasive Prenatal Testing Market Size, Growth & Global Forecast Report to 2028
The global Noninvasive Prenatal Testing Market research report, published by Value Market Research, is designed to offer various market framework such as market size, portion, trends, growth path, value and factors that impact the current market dynamics over the forecast period 2020-2028. Most importantly, this report also provides the latest significant strategies adopted by major players along with their market share. The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Genesis Genetics (CooperSurgical, Inc.), Centogene N.V., Eurofins LifeCodexx GmbH, F. Hoffmann-La Roche Ltd (Ariosa Diagnostics), Progenity, Inc., Laboratory Corp. of America Holdings, Natera, Inc., Illumina, Inc. (Verinata Health, Inc.), MedGenome Labs Ltd., Myriad Women’s Health, Inc. (Myriad Genetics Inc/Counsyl, Inc.), QiagenQuest Diagnostics, Inc. This section ...